Terms ending in 2031
Every in-force patent on Aquesys, Inc.'s record whose computed term ends in 2031, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,393,153 | Methods for Intraocular Shunt Placement In force · High confidence | Aquesys, Inc. | In force | High confidence | |
| US 10,307,293 | Methods for Intraocular Shunt Placement In force · High confidence | Aquesys, Inc. | In force | High confidence | |
| US 9,095,411 | Devices for Deploying Intraocular Shunts In force · High confidence | Aquesys, Inc. | In force | High confidence | |
| US 9,877,866 | Intraocular Shunt Placement In force · High confidence | Aquesys, Inc. | In force | High confidence | |
| US 9,326,891 | Methods for Deploying Intraocular Shunts In force · Low confidence | Aquesys, Inc. | In force | Low confidence | |
| US 8,308,701 | Methods for Deploying Intraocular Shunts In force · High confidence | Aquesys, Inc. | In force | High confidence | |
| US 10,940,040 | Intraocular Shunt Placement In force · Medium confidence | Aquesys, Inc. | In force | Medium confidence | |
| US 8,852,136 | Methods for Placing a Shunt into the Intra-Scleral Space In force · High confidence | Aquesys, Inc. | In force | High confidence | |
| US 9,095,413 | Intraocular Shunt Manufacture In force · High confidence | Aquesys, Inc. | In force | High confidence | |
| US 9,113,994 | Intraocular Shunt Manufacture In force · High confidence | Aquesys, Inc. | In force | High confidence | |
| 5 more term ends in 2031 · Pro | |||||
10 of 15 patents shown. Soonest term end first, then patent number.
Pro members see all 15.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.